Figure 3. Adenoviral delivery of CT-1 to the liver promotes the growth of MC38 cell-derived hepatic metastasis. (A,B) AdCT-1 was intravenously injected two days before the intrahepatic administration of 5 × 10⁶ MC38 tumor cells. Experiments were performed in wild type (WT) (A) or CT-1^−/− (B) mice. Photographs of the dissected abdomen represent tumor progression at day 14. Percentages represent area of tumor referred to total liver surface, containing 100 pixels (4.2 mm × 5 mm) in each picture.